These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 11918822)

  • 1. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities.
    Hoffmann C; Stoykova BA; Nixon J; Glanville JM; Misso K; Drummond MF
    Value Health; 2002; 5(2):71-8. PubMed ID: 11918822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using economic evidence to support decision making: a case study of assertive community treatment within the UK National Service Framework for Mental Health.
    Nixon J; Phipps K; Glanville J; Mugford M; Drummond M
    Appl Health Econ Health Policy; 2002; 1(4):179-90. PubMed ID: 14619247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of economic evaluations in NHS decision-making: a review and empirical investigation.
    Williams I; McIver S; Moore D; Bryan S
    Health Technol Assess; 2008 Apr; 12(7):iii, ix-x, 1-175. PubMed ID: 18373906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economic decision-making: a comparison between UK and Spain.
    Corbacho B; Pinto-Prades JL
    Br Med Bull; 2012 Sep; 103(1):5-20. PubMed ID: 22833571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical review of health-related economic evaluations in Australia: implications for health policy.
    Salkeld G; Davey P; Arnolda G
    Health Policy; 1995 Feb; 31(2):111-25. PubMed ID: 10141252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A difficult balancing act: policy actors' perspectives on using economic evaluation to inform health-care coverage decisions under the Universal Health Insurance Coverage scheme in Thailand.
    Teerawattananon Y; Russell S
    Value Health; 2008 Mar; 11 Suppl 1():S52-60. PubMed ID: 18387068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bridging the gap: exploring the barriers to using economic evidence in healthcare decision making and strategies for improving uptake.
    Merlo G; Page K; Ratcliffe J; Halton K; Graves N
    Appl Health Econ Health Policy; 2015 Jun; 13(3):303-9. PubMed ID: 25288052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report.
    Ramsey SD; Willke RJ; Glick H; Reed SD; Augustovski F; Jonsson B; Briggs A; Sullivan SD
    Value Health; 2015 Mar; 18(2):161-72. PubMed ID: 25773551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of economic evaluation in health care: Australian decision makers' perceptions.
    Ross J
    Health Policy; 1995 Feb; 31(2):103-10. PubMed ID: 10141251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of economic evaluation in decision making: what needs to change?
    Hutton J; Brown RE
    Value Health; 2002; 5(2):65-6. PubMed ID: 11918820
    [No Abstract]   [Full Text] [Related]  

  • 11. Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? : a critical review of published Korean economic evaluations.
    Lee KS; Brouwer WB; Lee SI; Koo HW
    Pharmacoeconomics; 2005; 23(7):709-21. PubMed ID: 15987227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The U.K. NHS economic evaluation database. Economic issues in evaluations of health technology.
    Nixon J; Stoykova B; Glanville J; Christie J; Drummond M; Kleijnen J
    Int J Technol Assess Health Care; 2000; 16(3):731-42. PubMed ID: 11028129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalised cost-effectiveness analysis: an aid to decision making in health.
    Hutubessy RC; Baltussen RM; Torres-Edejer TT; Evans DB
    Appl Health Econ Health Policy; 2002; 1(2):89-95. PubMed ID: 14619255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of economic evaluation in local health care decision-making in England: a qualitative investigation.
    Eddama O; Coast J
    Health Policy; 2009 Mar; 89(3):261-70. PubMed ID: 18657336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluations of health technologies in Dutch healthcare decision-making: a qualitative study of the current and potential use, barriers, and facilitators.
    Roseboom KJ; van Dongen JM; Tompa E; van Tulder MW; Bosmans JE
    BMC Health Serv Res; 2017 Jan; 17(1):89. PubMed ID: 28126005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research into the use of health economics in decision making in the United Kingdom--Phase II. Is health economics 'for good or evil'?
    Duthie T; Trueman P; Chancellor J; Diez L
    Health Policy; 1999 Jan; 46(2):143-57. PubMed ID: 10346286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision makers' views on health care objectives and budget constraints: results from a pilot study.
    Al MJ; Feenstra T; Brouwer WB
    Health Policy; 2004 Oct; 70(1):33-48. PubMed ID: 15312708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling in the economic evaluation of health care: selecting the appropriate approach.
    Barton P; Bryan S; Robinson S
    J Health Serv Res Policy; 2004 Apr; 9(2):110-8. PubMed ID: 15099459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.